tiprankstipranks
Advertisement
Advertisement

SelectQuote Faces NYSE Listing Compliance Challenge Amid Pressure

Story Highlights
  • On March 19, 2026, SelectQuote was flagged by the NYSE for non-compliance after its average share price fell below $1.
  • SelectQuote plans to cure the deficiency during a six-month window, leveraging strong recent results and a new $415 million credit facility to support its position.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
SelectQuote Faces NYSE Listing Compliance Challenge Amid Pressure

Claim 30% Off TipRanks

SelectQuote ( (SLQT) ) has issued an update.

On March 19, 2026, SelectQuote received a notice from the New York Stock Exchange that it was no longer in compliance with listing standards because its average share price had fallen below $1 over a 30‑day trading period. The company’s stock will remain listed during a six‑month cure period, during which SelectQuote aims to restore its share price to at least $1 on both a month‑end closing basis and a trailing 30‑day average.

Management has notified the NYSE of its intention to cure the deficiency and is prepared to consider shareholder‑approved measures if needed to preserve the listing. The notice comes after SelectQuote reported strong fiscal second‑quarter 2026 results in early February and secured a new $415 million credit facility extending most debt maturities to 2031, moves that bolster liquidity and operating flexibility even as the company confronts pressure on its stock price and the risk of eventual delisting if compliance is not regained.

The most recent analyst rating on (SLQT) stock is a Hold with a $0.71 price target. To see the full list of analyst forecasts on SelectQuote stock, see the SLQT Stock Forecast page.

Spark’s Take on SLQT Stock

According to Spark, TipRanks’ AI Analyst, SLQT is a Neutral.

The score is driven primarily by improving fundamentals (profitability recovery and meaningfully reduced leverage) and a constructive earnings outlook centered on higher expected operating cash flow, but it is capped by weak technicals (price well below key moving averages with negative momentum) and inconsistent cash flow conversion, with valuation metrics offering limited support due to a negative P/E and no dividend.

To see Spark’s full report on SLQT stock, click here.

More about SelectQuote

SelectQuote, Inc., founded in 1985 and listed on the NYSE under ticker SLQT, operates in the insurance and healthcare services industry, providing consumers with unbiased comparisons of policies from multiple highly rated insurers. The company’s ecosystem now spans insurance, Medicare, pharmacy, virtual care and value‑based care through three core business lines: SelectQuote Senior, SelectQuote Healthcare Services and SelectQuote Life.

SelectQuote Senior targets the fast-growing U.S. Medicare-eligible population with Medicare Advantage and Medicare Supplement plans, while SelectQuote Healthcare Services integrates its SelectRx pharmacy, chronic care management and broader healthcare navigation offerings. Proprietary lead-routing technology and a large force of trained agents underpin the company’s consultative sales model and support its multi-vertical expansion strategy.

Average Trading Volume: 1,501,013

Technical Sentiment Signal: Sell

Current Market Cap: $117.5M

For an in-depth examination of SLQT stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1